| CAT No: | CL-CPMH-03 |
| CAS No: | 50370-12-2 |
| Mol.F: | C16H17N3O5S |
| Mol.Wt.: | 363.4 |
| Chemical Name: | (6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Cefprozil Monohydrate EP Impurity B is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Cefprozil Monohydrate EP Impurity B is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Country of Origin: India Product Category: Impurity Reference StandardAPI NAME: Cefprozil Monohydrate Molecular Formula: C16H17N3O5S
Molecular Weight: 363.4
Storage: Store in a cool, dry place.
| Product Name: | Cefprozil Monohydrate EP Impurity B |
| CAS No: | 50370-12-2 |
| Mol.F.: | C16H17N3O5S |
| Mol.Wt.: | 363.4 |
Cat. No: CL-CPMH-01
CAS No: 121123-17-9
Mol. F: C18H19N3O5S : H2O
Mol. Wt: 389.4 : 18.0
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-02
CAS No: 22818-40-2
Mol. F: C8H9NO3
Mol. Wt: 167.2
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-04
CAS No: 147103-93-3
Mol. F: C11H11N3O3
Mol. Wt: 233.2
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-05
CAS No: 106447-44-3
Mol. F: C10H12N2O3S
Mol. Wt: 240.3
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-06
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-07
CAS No: 107937-01-9
Mol. F: C10H12N2O3S
Mol. Wt: 240.3
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-08
CAS No: NA
Mol. F: C18H21N3O6S
Mol. Wt: 407.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-09
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-10
CAS No: NA
Mol. F: C18H21N3O6S
Mol. Wt: 407.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-11
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-12
CAS No: NA
Mol. F: C18H19N3O5S
Mol. Wt: 389.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-13
CAS No: 203007-73-2
Mol. F: C10H13NO4
Mol. Wt: 211.2
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-14
CAS No: 1605314-84-8
Mol. F: C21H23N3O7S
Mol. Wt: 461.5
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-15
CAS No: 1605314-85-9
Mol. F: C21H23N3O7S
Mol. Wt: 461.5
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-16
CAS No: 1000980-59-5
Mol. F: C18H19N3O5S
Mol. Wt: 389.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-17
CAS No: 121412-77-9
Mol. F: C18H19N3O5S
Mol. Wt: 389.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-18
CAS No: 92676-86-3
Mol. F: C18H19N3O5S
Mol. Wt: 389.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-19
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-20
CAS No: NA
Mol. F: C36H36N6O9S2
Mol. Wt: 760.8
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-21
CAS No: NA
Mol. F: C21H23N3O7S
Mol. Wt: 461.5
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-22
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-23
CAS No: 110764-35-7
Mol. F: C18H19N3O5S
Mol. Wt: 389.4
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-24
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Cat. No: CL-CPMH-25
CAS No: NA
Mol. F: C26H26N4O7S
Mol. Wt: 538.6
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: